U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X ] Form 10-K [ ] Form 20-F [ ] 11-K [] Form 10-Q [ ] Form N-SAR
For Period Ended: April 30, 1999
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period
Ended:
__________________________________________
__________________________________________________________________________
Nothing in this form shall be construed to imply that the
Commission
has verified any information contained herein.
__________________________________________________________________________
If the notification relates to a portion of the filing checked
above,
identify the Item(s) to which the notification
relates:
___________________
___________________________________________________________________________
__________________________________________________________________________
Part I - Registrant Information Part I - Registrant Information
___________________________________________________________________________
Full Name of Registrant: Biosynergy, Inc.
Former Name if Applicable: Not Applicable
Address of Principal Executive Office (Street and Number): 1940
E.
Devon Avenue, Elk Grove Village, Illinois 60007
__________________________________________________________________________
Part II - Rules 12b-25 (b) and (c) Part II - Rules 12b-25 (b) and (c)
___________________________________________________________________________
If the subject report could not be filed without unreasonable
effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the
following should be completed. (Check box if appropriate) [X] Yes [ ] No
(a) The reasons described in reasonable detail in Part III of
this
form could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual, transition report on
Form
10-K; Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on
or
before the fifteenth calendar day following the prescribed due date; or
the
subject quarterly report or transition report on Form 10-Q, or
portion
thereof will be file don or before the fifth calendar day following
the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-
25(c) has been attached if applicable.
Federal Securities Laws Section
33,321
Part III - Narrative Part III - Narrative
___________________________________________________________________________
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K,
10-
Q, N-SAR or the transition report or portion thereof could not be
filed
within the prescribed time period.
Form 10-K was originally sent on July 19, 1999 by FedEx Priority
Overnight delivery, eight days prior to the due date. Filer Support called
the office of the preparer to inform him of the error, but the message was
not
received until the following week. An attempt was made to file Form 10-K
electronically, but this was unsuccessful due to technical problems. The
Form
10-K was filed on July 28, 1999, one day late.
Part IV - Other Information Part IV - Other Information
___________________________________________________________________________
(1) Name and telephone number of person to contract in regard to
this
notification Lauane C. Addis (312)
236-4111
_____________________________________________________________
(Name) (Area Code) (Telephone No.)
(2) Have all other periodic reports required under section 13 or 15(d)
of
the Securities Exchange Act of 1934 or section 30 of the Investment
Company
Act of 1940 during the preceding 12 months or for such shorter period
that
the registrant was required to file such report(s) been filed? If
the
answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations
from the corresponding period for the last fiscal year will be reflected
by
the earnings statements to be included in the subject report or
portion
thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable
estimate of the results cannot be made.
Biosynergy,
Inc.
___________________________________________________________________________
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned
thereunto duly authorized.
Date July 27, 1999
By:
____________________________ ____________________________________
Lauane C. Addis, Secretary
INSTRUCTION: The form may be signed by an executive officer of
the
registrant or by any other duly authorized representative. The name
and
title of the person signing the form shall be typed or printed beneath
the
signature. If the statement is signed on behalf of the registrant by
an
authorized representative (other than an executive officer), evidence
of
the representative's authority to sign on behalf of the registrant shall
be
filed with the form.
___________________________________________________________________________
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal
Criminal Violations (See 18 U.S.C. 1001).
